Adjuvant Interferon Alfa for Melanoma
British Columbia Cancer Agency, Vancouver Island Centre, 2410 Lee Avenue, Victoria, BC V8R 6V5, Canada
Curr. Oncol. 2010, 17(3), 6-7; https://doi.org/10.3747/co.v17i3.511
Submission received: 1 May 2010
/
Revised: 3 May 2010
/
Accepted: 6 May 2010
/
Published: 1 June 2010
Excerpt
Note: In lieu of an abstract, this is an excerpt from the first page.
The author poses the question “Why did these study results not lead to a global consensus about interferon treatment as standard of care?” [...]
Keywords:
melanoma; adjuvant; interferon
Share and Cite
MDPI and ACS Style
Wilson, K.S.; Attwell, A. Adjuvant Interferon Alfa for Melanoma. Curr. Oncol. 2010, 17, 6-7. https://doi.org/10.3747/co.v17i3.511
AMA Style
Wilson KS, Attwell A. Adjuvant Interferon Alfa for Melanoma. Current Oncology. 2010; 17(3):6-7. https://doi.org/10.3747/co.v17i3.511
Chicago/Turabian StyleWilson, Kenneth S., and Andrew Attwell. 2010. "Adjuvant Interferon Alfa for Melanoma" Current Oncology 17, no. 3: 6-7. https://doi.org/10.3747/co.v17i3.511
